Lactobacillus GG in the Prophylaxis of Ventilator Associated Pneumonia

PHASE3CompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

August 31, 2004

Primary Completion Date

August 31, 2009

Study Completion Date

November 30, 2009

Conditions
PneumoniaVentilator Associated Pneumonia
Interventions
DIETARY_SUPPLEMENT

Lactobacillus GG

Every 12 hours, the contents of a single capsule containing Lactobacillus GG will be suspended in 3 ml of water-soluble jelly. The suspension will be applied to the oropharyngeal mucosa via sterile syringe. The contents of a second capsule will be suspended in 10 ml of sterile water and pushed through the NG tub followed by 10 mL of air to ensure complete administration.

DIETARY_SUPPLEMENT

placebo

Every 12 hours, the contents of a single identical placebo capsule containing the inert plant carbohydrate inulin will be suspended in 3 ml of water-soluble jelly. This suspension will be applied to the oropharyngeal mucosa via sterile syringe. The contents of a second placebo capsule will be suspended in 10 ml of sterile water and pushed through eh NG tube followed by 10 mL of air to ensure complete administration

Trial Locations (1)

68131

Creighton University Medical Center, Omaha

All Listed Sponsors
lead

Creighton University

OTHER

NCT00613795 - Lactobacillus GG in the Prophylaxis of Ventilator Associated Pneumonia | Biotech Hunter | Biotech Hunter